- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01309503
Speech Intelligibility in Noise Using the Hearing in Noise Test (HINT)
Speech Intelligibility in Noise and Estimation of Binaural Benefits Using the Hearing in Noise Test (HINT). Studies on Normal Hearing Children and Adults, Groups of Hearing Aid Users and Cochlea Implant Users.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Marte Myhrum, M.Sc
- Phone Number: 004723071691
- Email: marte.myhrum@oslo-universitetssykehus.no
Study Locations
-
-
-
Oslo, Norway
- Recruiting
- Oslo University Hospital
-
Contact:
- Marte Myhrum, M.Sc
- Phone Number: 004723071691
- Email: marte.myhrum@oslo-universitetssykehus.no
-
Principal Investigator:
- Marte Myhrum, M.Sc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria for the different groups:
Normal hearing group (note that some subjects are already recruited in the normal hearing group):
- audiometric thresholds less than or equal to 25 dB HL for octave frequencies between 250 Hz and 8000 Hz
- Adults between age 18 and 50 years
- Children at different age groups between 6 and 12 years old
Unilateral hearing loss group
- Single-sided hearing loss.
- Using hearing aid or willing to try hearing aid on the side with hearing loss to estimate a potential binaural benefit with hearing aid.
- Unilateral hearing loss inclusion criteria is thresholds within 25 dBHL and 70 dBHL for frequencies {125,250,500} Hz. Inclusion region increasing linearly with octave frequency to 40 dBHL and 95 dBHL for frequency 8000Hz. In addition a single threshold outside this hearing threshold inclusion region is accepted.
- Contralateral normal hearing with audiometric thresholds less than or equal to 25 dB HL for octave frequencies between 250 Hz and 8000 Hz
Group with Severe hearing loss at high frequencies
- Inclusion criteria is bilateral hearing loss within hearing levels where frequencies below 750 Hz can be normal or elevated down to 65 dBHL, for frequencies 1000 Hz and 1500 Hz all HL thresholds are accepted, frequencies 2000 Hz and above have threshold criteria 85 dBHL or above.
Adult CI users with unilateral and bilateral CI
- All adult patients will be tested to the level of their performance.
- HINT SRTs will be collected if HINT score in quiet is above 70%.
Bilateral CI users (Children)
Sequential CIs group
- Children that has got two CIs in two different operations, and operations are not within one year.
- Inclusion of some of the patients participating in another ongoing sequential CI-study at the ENT department,and who has a HINT score above 70% in quiet. The requirement of a quiet percentage score above 70% is due to the bilateral benefit testing/estimation.
Simultaneous CIs group
- All children that has got two CIs in the same operation or sequentially within one year.
- Children older than 6 years old.
- Children as young as 5.5 years old can be included if they are considered ready for extended HINT testing.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Normal hearing
Children and adults
|
Unilateral hearing loss
|
Severe hearing loss high frequencies
|
Adult CI users
Unilateral and bilateral CI
|
Bilateral CI users
Children and adults Sequential CIs Simultaneous CIs |
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marte Myhrum, M.Sc., Oslo University Hospital
- Study Chair: Greg Jablonski, PhD, Oslo University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2010/743a (REK )
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Speech Intelligibility
-
University of Maryland, College ParkNational Institute on Aging (NIA)Completed
-
University of UtahNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Nursing... and other collaboratorsCompletedNoninvasive Ventilation | Speech IntelligibilityUnited States
-
University of Maryland, College ParkNational Institute on Aging (NIA)Recruiting
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedHead and Neck Cancer | Speech Disorders | Speech Intelligibility | Speech | Speech DysfunctionTurkey
-
Altec Inc.RecruitingSpeech Disorders | Speech Perception | Rehabilitation of Speech and Language Disorders | Speech, Alaryngeal | Communication Aids for Disabled | Speech IntelligibilityUnited States
-
Utah State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedIntelligibility, Speech | DysarthriaUnited States
-
University of Central FloridaNational Institute on Deafness and Other Communication Disorders (NIDCD); University...CompletedDown Syndrome | Speech Sound Disorder | Speech Disorders in Children | Speech Intelligibility | Speech and Language DisorderUnited States
-
Aaron NewmanUniversity of Oslo; CogniFit LimitedTerminatedDeafness | Speech IntelligibilityCanada
-
Archean TechnologiesRecruitingSpeech Intelligibility in NoiseFrance
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Marguerite-Marie DelacroixCompletedDown Syndrome | Stuttering | Intelligibility, Speech | GesturesBelgium